Difference between revisions of "Team:Tianjin/Design"

Line 233: Line 233:
 
  <h4>2. Construction of systems</h4>
 
  <h4>2. Construction of systems</h4>
 
           <hr>
 
           <hr>
         <h5> (1) Gal System. </h5>
+
         <h5> (1) Gal System</h5>
            <hr>
+
         
 
         <p>In this pathway, we chose Gal1 as our promoter for the expression of HO gene, CYC1 as the terminator, and PRS416(with Ura-tag) as our vector. As for segments ligation, we design the cutting sites for Bsa1 enzyme in each part, hoping to achieve seamless ligation of these three parts. </p>
 
         <p>In this pathway, we chose Gal1 as our promoter for the expression of HO gene, CYC1 as the terminator, and PRS416(with Ura-tag) as our vector. As for segments ligation, we design the cutting sites for Bsa1 enzyme in each part, hoping to achieve seamless ligation of these three parts. </p>
 
           <p>We adopted the PCR method to amplify the Gal1-part and CYC1-part from a Gal1-Vika plasmid we had used in our former lab work. We designed specific primers for this procedure. After PCR, the Gal1 has the cutting sites for SalⅠand BsaⅠon both ends, and CYC1 has that for BsaⅠand BamhⅠon both ends. Meanwhile, the HO gene was obtained by gene synthesis, flanked by specific hangtags for BsaⅠto be cohesive with Gal1 upstream and CYC1 downstream. Thus, we have built our composite part (GHC).</p>
 
           <p>We adopted the PCR method to amplify the Gal1-part and CYC1-part from a Gal1-Vika plasmid we had used in our former lab work. We designed specific primers for this procedure. After PCR, the Gal1 has the cutting sites for SalⅠand BsaⅠon both ends, and CYC1 has that for BsaⅠand BamhⅠon both ends. Meanwhile, the HO gene was obtained by gene synthesis, flanked by specific hangtags for BsaⅠto be cohesive with Gal1 upstream and CYC1 downstream. Thus, we have built our composite part (GHC).</p>
 
       <p>After the ligation, we transformed the E.coli for the augment of the PRS416 plasmid with GHC. (GHC-416) And eventually, we transformed our SynⅩ-dUra for the GHC-416 to get our target yeasts——SynⅩ-dUra-416. </p>
 
       <p>After the ligation, we transformed the E.coli for the augment of the PRS416 plasmid with GHC. (GHC-416) And eventually, we transformed our SynⅩ-dUra for the GHC-416 to get our target yeasts——SynⅩ-dUra-416. </p>
  
         <h5> (2) Modified. Gal1 system. </h5>
+
         <h5> (2) Modified. Gal1 system </h5>
             <hr>
+
              
 
         <p>In this pathway, we introduced one kind of artificial transcription factor (ATF)—Z4EV into the  regulation of HO gene expression. With Z4EV working with our Modified. Gal1 promoter, we hoped to reach the on off-target dynamic control of HO gene expression.  
 
         <p>In this pathway, we introduced one kind of artificial transcription factor (ATF)—Z4EV into the  regulation of HO gene expression. With Z4EV working with our Modified. Gal1 promoter, we hoped to reach the on off-target dynamic control of HO gene expression.  
 
Our designing for getting the Modified. Gal1-HO-CYC1 parts (MGHC) is quite the same as that for GHC mentioned above, only that we acquired our Modified. Gal1 part from the gene synthesis. (P2)</p>
 
Our designing for getting the Modified. Gal1-HO-CYC1 parts (MGHC) is quite the same as that for GHC mentioned above, only that we acquired our Modified. Gal1 part from the gene synthesis. (P2)</p>
 +
        <p>As for the expression of Z4EV gene, we intended to induce it into the SynX chromosome in SynⅩ-dUra by homologous recombination. With overlap PCR strategy, we put an homologous domain CanA (originally from Can gene in chromosome X) in the upstream of the promoter of Z4EV. Thus, we got our CanA-TEF-Z4EV part. Then we planned to use Tdh2t as terminator attached with Leu-CanB (another part of Can gene). </p>
 +
 +
        <p>Next, for double using the Leu-tag, we introduce Vika/vox system. We intended to attach the Vika operator (Tdh3p-Vikc-Tdh2t, TVT) following the Z4EV gene. We had two groups of yeasts, as mentioned above, one of them aimed to accomplish MTS and becoming MATα, the other with functional genes remained as MATa. According to our design, the former will express Vika recombinase, and the other contain functional genes whose expressions are controlled by vox-Terminator-vox structure. Thus, the function gene’s expression will be initiate during the cell fusion in yeast mating process. (P3) </p>
 +
  
  

Revision as of 11:31, 26 October 2017

/* OVERRIDE IGEM SETTINGS */

Design


Background

Human existence on earth is almost impossible without the heavy metals. Even though important to mankind, exposure to them during production, usage and their uncontrolled discharge in to the environment has caused lots of hazards to man, other organisms and the environment itself. Heavy metals can enter human tissues and organs via inhalation, diet, and manual handling. As the process of urbanization and industrialization goes deeper and deeper, heavy metal pollution, a noticeable threaten to almost all the creatures, has become an essential problem to solve.

According to our human practice, the situation of heavy metal pollution (copper and cadmium ions) is marked on a world map, and the severity of heavy metal pollution has been increasing all over this map. Places with serious pollution includes middle Asia, eastern Asia, southern Europe, and Latin America. In addition, not only fresh water sources, but also soil and crops are seriously contaminated by heavy metals. On average, during three out of ten suppers we have, we absorb excess heavy metals over the standard concentration.

Considering the rigorous situation we face, our team decided to design an advanced system for typical toxic heavy metal disposal based on Saccharomyces cerevisiae.